カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のリファンピシン市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Rifampicin Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19604）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19604
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：97
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のリファンピシン市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

リファンピシン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のリファンピシンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

リファンピシン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・経口、静脈内注射

用途別セグメントは次のように区分されます。
・結核、ハンセン病、レジオネラ症、その他

世界のリファンピシン市場の主要な市場プレーヤーは以下のとおりです。
・Sanofi、Wellona Pharma、AVANSCURE LIFESCIENCES、Hebei Xingang Pharmaceutical、Mercator Pharmaceutical Solutions、ASIAN PHARMACY

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、リファンピシン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なリファンピシンメーカーの企業概要、2019年～2022年までのリファンピシンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なリファンピシンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別リファンピシンの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのリファンピシンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのリファンピシン市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびリファンピシンの産業チェーンを掲載しています。
・第13、14、15章では、リファンピシンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- リファンピシンの概要
- 種類別分析（2017年vs2021年vs2028年）：経口、静脈内注射
- 用途別分析（2017年vs2021年vs2028年）：結核、ハンセン病、レジオネラ症、その他
- 世界のリファンピシン市場規模・予測
- 世界のリファンピシン生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Sanofi、Wellona Pharma、AVANSCURE LIFESCIENCES、Hebei Xingang Pharmaceutical、Mercator Pharmaceutical Solutions、ASIAN PHARMACY
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：経口、静脈内注射
・用途別分析2017年-2028年：結核、ハンセン病、レジオネラ症、その他
・リファンピシンの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・リファンピシンのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・リファンピシンのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・リファンピシンの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・リファンピシンの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Rifampicin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Rifampicin market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Tuberculosis accounting for % of the Rifampicin global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Oral segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Rifampicin include Sanofi, Wellona Pharma, AVANSCURE LIFESCIENCES, Hebei Xingang Pharmaceutical, and Mercator Pharmaceutical Solutions, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Rifampicin market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Oral
Intravenous Injection
Market segment by Application can be divided into
Tuberculosis
Leprosy
Legionnaire’s Disease
Others
The key market players for global Rifampicin market are listed below:
Sanofi
Wellona Pharma
AVANSCURE LIFESCIENCES
Hebei Xingang Pharmaceutical
Mercator Pharmaceutical Solutions
ASIAN PHARMACY
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Rifampicin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Rifampicin, with price, sales, revenue and global market share of Rifampicin from 2019 to 2022.
Chapter 3, the Rifampicin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Rifampicin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Rifampicin market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Rifampicin.
Chapter 13, 14, and 15, to describe Rifampicin sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Rifampicin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Rifampicin Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Oral
1.2.3 Intravenous Injection
1.3 Market Analysis by Application
1.3.1 Overview: Global Rifampicin Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Tuberculosis
1.3.3 Leprosy
1.3.4 Legionnaire’s Disease
1.3.5 Others
1.4 Global Rifampicin Market Size & Forecast
1.4.1 Global Rifampicin Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Rifampicin Sales in Volume (2017-2028)
1.4.3 Global Rifampicin Price (2017-2028)
1.5 Global Rifampicin Production Capacity Analysis
1.5.1 Global Rifampicin Total Production Capacity (2017-2028)
1.5.2 Global Rifampicin Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Rifampicin Market Drivers
1.6.2 Rifampicin Market Restraints
1.6.3 Rifampicin Trends Analysis
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Rifampicin Product and Services
2.1.4 Sanofi Rifampicin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Wellona Pharma
2.2.1 Wellona Pharma Details
2.2.2 Wellona Pharma Major Business
2.2.3 Wellona Pharma Rifampicin Product and Services
2.2.4 Wellona Pharma Rifampicin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 AVANSCURE LIFESCIENCES
2.3.1 AVANSCURE LIFESCIENCES Details
2.3.2 AVANSCURE LIFESCIENCES Major Business
2.3.3 AVANSCURE LIFESCIENCES Rifampicin Product and Services
2.3.4 AVANSCURE LIFESCIENCES Rifampicin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Hebei Xingang Pharmaceutical
2.4.1 Hebei Xingang Pharmaceutical Details
2.4.2 Hebei Xingang Pharmaceutical Major Business
2.4.3 Hebei Xingang Pharmaceutical Rifampicin Product and Services
2.4.4 Hebei Xingang Pharmaceutical Rifampicin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Mercator Pharmaceutical Solutions
2.5.1 Mercator Pharmaceutical Solutions Details
2.5.2 Mercator Pharmaceutical Solutions Major Business
2.5.3 Mercator Pharmaceutical Solutions Rifampicin Product and Services
2.5.4 Mercator Pharmaceutical Solutions Rifampicin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 ASIAN PHARMACY
2.6.1 ASIAN PHARMACY Details
2.6.2 ASIAN PHARMACY Major Business
2.6.3 ASIAN PHARMACY Rifampicin Product and Services
2.6.4 ASIAN PHARMACY Rifampicin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Rifampicin Breakdown Data by Manufacturer
3.1 Global Rifampicin Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Rifampicin Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Rifampicin
3.4 Market Concentration Rate
3.4.1 Top 3 Rifampicin Manufacturer Market Share in 2021
3.4.2 Top 6 Rifampicin Manufacturer Market Share in 2021
3.5 Global Rifampicin Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Rifampicin Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Rifampicin Market Size by Region
4.1.1 Global Rifampicin Sales in Volume by Region (2017-2028)
4.1.2 Global Rifampicin Revenue by Region (2017-2028)
4.2 North America Rifampicin Revenue (2017-2028)
4.3 Europe Rifampicin Revenue (2017-2028)
4.4 Asia-Pacific Rifampicin Revenue (2017-2028)
4.5 South America Rifampicin Revenue (2017-2028)
4.6 Middle East and Africa Rifampicin Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Rifampicin Sales in Volume by Type (2017-2028)
5.2 Global Rifampicin Revenue by Type (2017-2028)
5.3 Global Rifampicin Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Rifampicin Sales in Volume by Application (2017-2028)
6.2 Global Rifampicin Revenue by Application (2017-2028)
6.3 Global Rifampicin Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Rifampicin Sales by Type (2017-2028)
7.2 North America Rifampicin Sales by Application (2017-2028)
7.3 North America Rifampicin Market Size by Country
7.3.1 North America Rifampicin Sales in Volume by Country (2017-2028)
7.3.2 North America Rifampicin Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Rifampicin Sales by Type (2017-2028)
8.2 Europe Rifampicin Sales by Application (2017-2028)
8.3 Europe Rifampicin Market Size by Country
8.3.1 Europe Rifampicin Sales in Volume by Country (2017-2028)
8.3.2 Europe Rifampicin Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Rifampicin Sales by Type (2017-2028)
9.2 Asia-Pacific Rifampicin Sales by Application (2017-2028)
9.3 Asia-Pacific Rifampicin Market Size by Region
9.3.1 Asia-Pacific Rifampicin Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Rifampicin Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Rifampicin Sales by Type (2017-2028)
10.2 South America Rifampicin Sales by Application (2017-2028)
10.3 South America Rifampicin Market Size by Country
10.3.1 South America Rifampicin Sales in Volume by Country (2017-2028)
10.3.2 South America Rifampicin Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Rifampicin Sales by Type (2017-2028)
11.2 Middle East & Africa Rifampicin Sales by Application (2017-2028)
11.3 Middle East & Africa Rifampicin Market Size by Country
11.3.1 Middle East & Africa Rifampicin Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Rifampicin Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Rifampicin and Key Manufacturers
12.2 Manufacturing Costs Percentage of Rifampicin
12.3 Rifampicin Production Process
12.4 Rifampicin Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Rifampicin Typical Distributors
13.3 Rifampicin Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Rifampicin Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Rifampicin Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Major Business
Table 5. Sanofi Rifampicin Product and Services
Table 6. Sanofi Rifampicin Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Wellona Pharma Basic Information, Manufacturing Base and Competitors
Table 8. Wellona Pharma Major Business
Table 9. Wellona Pharma Rifampicin Product and Services
Table 10. Wellona Pharma Rifampicin Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. AVANSCURE LIFESCIENCES Basic Information, Manufacturing Base and Competitors
Table 12. AVANSCURE LIFESCIENCES Major Business
Table 13. AVANSCURE LIFESCIENCES Rifampicin Product and Services
Table 14. AVANSCURE LIFESCIENCES Rifampicin Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Hebei Xingang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 16. Hebei Xingang Pharmaceutical Major Business
Table 17. Hebei Xingang Pharmaceutical Rifampicin Product and Services
Table 18. Hebei Xingang Pharmaceutical Rifampicin Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Mercator Pharmaceutical Solutions Basic Information, Manufacturing Base and Competitors
Table 20. Mercator Pharmaceutical Solutions Major Business
Table 21. Mercator Pharmaceutical Solutions Rifampicin Product and Services
Table 22. Mercator Pharmaceutical Solutions Rifampicin Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. ASIAN PHARMACY Basic Information, Manufacturing Base and Competitors
Table 24. ASIAN PHARMACY Major Business
Table 25. ASIAN PHARMACY Rifampicin Product and Services
Table 26. ASIAN PHARMACY Rifampicin Sales (MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Global Rifampicin Sales by Manufacturer (2019, 2020, 2021, and 2022) & (MT)
Table 28. Global Rifampicin Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 29. Market Position of Manufacturers in Rifampicin, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 30. Global Rifampicin Production Capacity by Company, (MT): 2020 VS 2021
Table 31. Head Office and Rifampicin Production Site of Key Manufacturer
Table 32. Rifampicin New Entrant and Capacity Expansion Plans
Table 33. Rifampicin Mergers & Acquisitions in the Past Five Years
Table 34. Global Rifampicin Sales by Region (2017-2022) & (MT)
Table 35. Global Rifampicin Sales by Region (2023-2028) & (MT)
Table 36. Global Rifampicin Revenue by Region (2017-2022) & (USD Million)
Table 37. Global Rifampicin Revenue by Region (2023-2028) & (USD Million)
Table 38. Global Rifampicin Sales by Type (2017-2022) & (MT)
Table 39. Global Rifampicin Sales by Type (2023-2028) & (MT)
Table 40. Global Rifampicin Revenue by Type (2017-2022) & (USD Million)
Table 41. Global Rifampicin Revenue by Type (2023-2028) & (USD Million)
Table 42. Global Rifampicin Price by Type (2017-2022) & (USD/MT)
Table 43. Global Rifampicin Price by Type (2023-2028) & (USD/MT)
Table 44. Global Rifampicin Sales by Application (2017-2022) & (MT)
Table 45. Global Rifampicin Sales by Application (2023-2028) & (MT)
Table 46. Global Rifampicin Revenue by Application (2017-2022) & (USD Million)
Table 47. Global Rifampicin Revenue by Application (2023-2028) & (USD Million)
Table 48. Global Rifampicin Price by Application (2017-2022) & (USD/MT)
Table 49. Global Rifampicin Price by Application (2023-2028) & (USD/MT)
Table 50. North America Rifampicin Sales by Country (2017-2022) & (MT)
Table 51. North America Rifampicin Sales by Country (2023-2028) & (MT)
Table 52. North America Rifampicin Revenue by Country (2017-2022) & (USD Million)
Table 53. North America Rifampicin Revenue by Country (2023-2028) & (USD Million)
Table 54. North America Rifampicin Sales by Type (2017-2022) & (MT)
Table 55. North America Rifampicin Sales by Type (2023-2028) & (MT)
Table 56. North America Rifampicin Sales by Application (2017-2022) & (MT)
Table 57. North America Rifampicin Sales by Application (2023-2028) & (MT)
Table 58. Europe Rifampicin Sales by Country (2017-2022) & (MT)
Table 59. Europe Rifampicin Sales by Country (2023-2028) & (MT)
Table 60. Europe Rifampicin Revenue by Country (2017-2022) & (USD Million)
Table 61. Europe Rifampicin Revenue by Country (2023-2028) & (USD Million)
Table 62. Europe Rifampicin Sales by Type (2017-2022) & (MT)
Table 63. Europe Rifampicin Sales by Type (2023-2028) & (MT)
Table 64. Europe Rifampicin Sales by Application (2017-2022) & (MT)
Table 65. Europe Rifampicin Sales by Application (2023-2028) & (MT)
Table 66. Asia-Pacific Rifampicin Sales by Region (2017-2022) & (MT)
Table 67. Asia-Pacific Rifampicin Sales by Region (2023-2028) & (MT)
Table 68. Asia-Pacific Rifampicin Revenue by Region (2017-2022) & (USD Million)
Table 69. Asia-Pacific Rifampicin Revenue by Region (2023-2028) & (USD Million)
Table 70. Asia-Pacific Rifampicin Sales by Type (2017-2022) & (MT)
Table 71. Asia-Pacific Rifampicin Sales by Type (2023-2028) & (MT)
Table 72. Asia-Pacific Rifampicin Sales by Application (2017-2022) & (MT)
Table 73. Asia-Pacific Rifampicin Sales by Application (2023-2028) & (MT)
Table 74. South America Rifampicin Sales by Country (2017-2022) & (MT)
Table 75. South America Rifampicin Sales by Country (2023-2028) & (MT)
Table 76. South America Rifampicin Revenue by Country (2017-2022) & (USD Million)
Table 77. South America Rifampicin Revenue by Country (2023-2028) & (USD Million)
Table 78. South America Rifampicin Sales by Type (2017-2022) & (MT)
Table 79. South America Rifampicin Sales by Type (2023-2028) & (MT)
Table 80. South America Rifampicin Sales by Application (2017-2022) & (MT)
Table 81. South America Rifampicin Sales by Application (2023-2028) & (MT)
Table 82. Middle East & Africa Rifampicin Sales by Region (2017-2022) & (MT)
Table 83. Middle East & Africa Rifampicin Sales by Region (2023-2028) & (MT)
Table 84. Middle East & Africa Rifampicin Revenue by Region (2017-2022) & (USD Million)
Table 85. Middle East & Africa Rifampicin Revenue by Region (2023-2028) & (USD Million)
Table 86. Middle East & Africa Rifampicin Sales by Type (2017-2022) & (MT)
Table 87. Middle East & Africa Rifampicin Sales by Type (2023-2028) & (MT)
Table 88. Middle East & Africa Rifampicin Sales by Application (2017-2022) & (MT)
Table 89. Middle East & Africa Rifampicin Sales by Application (2023-2028) & (MT)
Table 90. Rifampicin Raw Material
Table 91. Key Manufacturers of Rifampicin Raw Materials
Table 92. Direct Channel Pros & Cons
Table 93. Indirect Channel Pros & Cons
Table 94. Rifampicin Typical Distributors
Table 95. Rifampicin Typical Customers
List of Figures
Figure 1. Rifampicin Picture
Figure 2. Global Rifampicin Revenue Market Share by Type in 2021
Figure 3. Oral
Figure 4. Intravenous Injection
Figure 5. Global Rifampicin Revenue Market Share by Application in 2021
Figure 6. Tuberculosis
Figure 7. Leprosy
Figure 8. Legionnaire's Disease
Figure 9. Others
Figure 10. Global Rifampicin Revenue, (USD Million) & (MT): 2017 & 2021 & 2028
Figure 11. Global Rifampicin Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Rifampicin Sales (2017-2028) & (MT)
Figure 13. Global Rifampicin Price (2017-2028) & (USD/MT)
Figure 14. Global Rifampicin Production Capacity (2017-2028) & (MT)
Figure 15. Global Rifampicin Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Rifampicin Market Drivers
Figure 17. Rifampicin Market Restraints
Figure 18. Rifampicin Market Trends
Figure 19. Global Rifampicin Sales Market Share by Manufacturer in 2021
Figure 20. Global Rifampicin Revenue Market Share by Manufacturer in 2021
Figure 21. Rifampicin Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Rifampicin Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Rifampicin Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Rifampicin Sales Market Share by Region (2017-2028)
Figure 25. Global Rifampicin Revenue Market Share by Region (2017-2028)
Figure 26. North America Rifampicin Revenue (2017-2028) & (USD Million)
Figure 27. Europe Rifampicin Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Rifampicin Revenue (2017-2028) & (USD Million)
Figure 29. South America Rifampicin Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Rifampicin Revenue (2017-2028) & (USD Million)
Figure 31. Global Rifampicin Sales Market Share by Type (2017-2028)
Figure 32. Global Rifampicin Revenue Market Share by Type (2017-2028)
Figure 33. Global Rifampicin Price by Type (2017-2028) & (USD/MT)
Figure 34. Global Rifampicin Sales Market Share by Application (2017-2028)
Figure 35. Global Rifampicin Revenue Market Share by Application (2017-2028)
Figure 36. Global Rifampicin Price by Application (2017-2028) & (USD/MT)
Figure 37. North America Rifampicin Sales Market Share by Type (2017-2028)
Figure 38. North America Rifampicin Sales Market Share by Application (2017-2028)
Figure 39. North America Rifampicin Sales Market Share by Country (2017-2028)
Figure 40. North America Rifampicin Revenue Market Share by Country (2017-2028)
Figure 41. United States Rifampicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Rifampicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Rifampicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Rifampicin Sales Market Share by Type (2017-2028)
Figure 45. Europe Rifampicin Sales Market Share by Application (2017-2028)
Figure 46. Europe Rifampicin Sales Market Share by Country (2017-2028)
Figure 47. Europe Rifampicin Revenue Market Share by Country (2017-2028)
Figure 48. Germany Rifampicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Rifampicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Rifampicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Rifampicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Rifampicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Rifampicin Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Rifampicin Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Rifampicin Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Rifampicin Revenue Market Share by Region (2017-2028)
Figure 57. China Rifampicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Rifampicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Rifampicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Rifampicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Rifampicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Rifampicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Rifampicin Sales Market Share by Type (2017-2028)
Figure 64. South America Rifampicin Sales Market Share by Application (2017-2028)
Figure 65. South America Rifampicin Sales Market Share by Country (2017-2028)
Figure 66. South America Rifampicin Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Rifampicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Rifampicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Rifampicin Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Rifampicin Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Rifampicin Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Rifampicin Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Rifampicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Rifampicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Rifampicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Rifampicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Rifampicin in 2021
Figure 78. Manufacturing Process Analysis of Rifampicin
Figure 79. Rifampicin Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の医薬品用キシリトール市場2022年：市場規模予測（～2028年）
  • 世界の製薬業用ポンプ市場2022年：市場規模予測（～2028年）
  • 世界の医薬品スクリーニング機市場2022年：市場規模予測（～2028年）
  • 世界の経口製剤用医薬品賦形剤市場2022年：市場規模予測（～2028年）
  • 世界の医薬品用魚油市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19604 )"世界のリファンピシン市場2022年：市場規模予測（～2028年）" (英文：Global Rifampicin Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。